Business Description
Sonendo Inc
NAICS : 339114
SIC : 3841
ISIN : US8354311073
Description
Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, theĀ prevalent chronic disease globally. It has developed the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The Company operates in two business segments, Product segment which derives key revenue, and Software. Product segment includes sales of the Company's GentleWave System console and related accessories and instruments. Software segment includes sales of the Company's traditional software licenses for practice management software to enable an integrated digital office for endodontists.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.36 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 1.01 | |||||
| Debt-to-EBITDA | -0.49 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -12.32 | |||||
| Beneish M-Score | -4.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -28.2 | |||||
| 3-Year EBITDA Growth Rate | 35 | |||||
| 3-Year EPS without NRI Growth Rate | 37.4 | |||||
| 3-Year FCF Growth Rate | 38.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.16 | |||||
| 9-Day RSI | 40.71 | |||||
| 14-Day RSI | 42.5 | |||||
| 6-1 Month Momentum % | -60.96 | |||||
| 12-1 Month Momentum % | -90.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.78 | |||||
| Quick Ratio | 2.14 | |||||
| Cash Ratio | 1.77 | |||||
| Days Inventory | 151.07 | |||||
| Days Sales Outstanding | 50.13 | |||||
| Days Payable | 22.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -51 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.33 | |||||
| Operating Margin % | -127.13 | |||||
| Net Margin % | -130.16 | |||||
| FCF Margin % | -101.12 | |||||
| ROE % | -123.17 | |||||
| ROA % | -57.95 | |||||
| ROIC % | -156.53 | |||||
| ROC (Joel Greenblatt) % | -314.69 | |||||
| ROCE % | -73.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.22 | |||||
| PB Ratio | 0.27 | |||||
| Price-to-Tangible-Book | 0.27 | |||||
| EV-to-EBIT | 0.05 | |||||
| EV-to-EBITDA | 0.05 | |||||
| EV-to-Revenue | -0.06 | |||||
| Price-to-Net-Current-Asset-Value | 0.32 | |||||
| Price-to-Net-Cash | 4.69 | |||||
| Earnings Yield (Greenblatt) % | 2000 | |||||
| FCF Yield % | -615.57 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers